Oncology Institute Inc (TOI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oncology Institute Inc (TOI) has a cash flow conversion efficiency ratio of 0.136x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.21 Million) by net assets ($-16.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TOI company net worth for the company's overall valuation and market capitalisation.
Oncology Institute Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Oncology Institute Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Oncology Institute Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncology Institute Inc ranked by their cash flow conversion efficiency. Explore earnings quality score of Oncology Institute Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
N/A |
|
Electrosteel Castings Limited
NSE:ELECTCAST
|
0.070x |
|
Autolus Therapeutics Ltd
NASDAQ:AUTL
|
-0.600x |
|
BlackRock MIT II
NYSE:BLE
|
-0.063x |
|
Jiangxi Huawu Brake Co Ltd
SHE:300095
|
0.039x |
|
Lem Holding SA
SW:LEHN
|
0.074x |
|
Penyao Environmental Protection Co Ltd Class A
SHE:300664
|
0.023x |
|
Shandong Homey Aquatic Development Co Ltd
SHG:600467
|
0.010x |
Annual Cash Flow Conversion Efficiency for Oncology Institute Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Oncology Institute Inc from 2019 to 2025. View Oncology Institute Inc stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-15.72 Million | $-24.59 Million | 1.564x | +121.15% |
| 2024-12-31 | $3.59 Million | $-26.54 Million | -7.394x | -1061.11% |
| 2023-12-31 | $57.02 Million | $-36.31 Million | -0.637x | -27.02% |
| 2022-12-31 | $123.17 Million | $-61.76 Million | -0.501x | -59.80% |
| 2021-12-31 | $104.16 Million | $-32.68 Million | -0.314x | -1835.57% |
| 2020-12-31 | $28.10 Million | $508.00K | 0.018x | -78.89% |
| 2019-12-31 | $42.22 Million | $3.62 Million | 0.086x | -- |
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as edu… Read more